SeaStar Medical Holding Corporation (ICU)
Market: NASD |
Currency: USD
Address: 3513 Brighton Boulevard
SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.
📈 SeaStar Medical Holding Corporation Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$7.00
-
Upside/Downside from Analyst Target:
616.99%
-
Broker Call:
2
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
50-100%
-
Net Income Growth Range (1Y):
50-100%
-
Revenue Growth Range (1Y):
-
💰 Dividend History
| Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
| 2024 |
- |
$0.040000 |
- |
2024-06-10 |
- |
Stock split |
|
Total Amount for 2024: $0.040000 |
📅 Earnings & EPS History for SeaStar Medical Holding Corporation
| Date | Reported EPS |
|---|
| 2026-05-12 (estimated upcoming) | - |
| 2026-03-25 (estimated upcoming) | - |
| 2025-11-11 (estimated upcoming) | - |
| 2025-11-10 (estimated upcoming) | - |
| 2025-08-11 (estimated upcoming) | - |
| 2025-08-10 (estimated upcoming) | - |
| 2025-05-14 | - |
| 2025-05-12 | - |
| 2025-05-11 | - |
| 2025-04-14 | - |
| 2025-04-13 | - |
| 2025-03-27 | -0.9 |
| 2024-11-13 | -1.1 |
| 2024-08-13 | -1.03 |
| 2024-08-12 | -1.03 |
| 2024-05-14 | -0.19 |
| 2024-05-13 | -0.19 |
| 2024-04-16 | -0.22 |
| 2024-04-15 | -0.22 |
| 2023-11-14 | -0.36 |
| 2023-11-13 | -0.36 |
| 2023-08-14 | -0.28 |
| 2023-08-13 | -0.28 |
| 2023-05-15 | - |
| 2023-05-14 | - |
📰 Related News & Research
No related articles found for "seastar medical".
